{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:26:02Z","timestamp":1787761562589,"version":"build-2784847793"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-024-11103-4","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:19:30Z","timestamp":1738981170000},"page":"6033-6058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacophore-based identification and in Silico characterization of microbial metabolites as potential modulators of Wnt signaling pathway in colorectal cancer therapy"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3376-0847","authenticated-orcid":false,"given":"Divya","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8834-8834","authenticated-orcid":false,"given":"Sivakumar","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"11103_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A et al (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72:338\u2013344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736","journal-title":"Gut"},{"key":"11103_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12307-010-0060-5","volume":"4","author":"D Gingras","year":"2011","unstructured":"Gingras D, B\u00e9liveau R (2011) Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenviron 4:133\u2013139. https:\/\/doi.org\/10.1007\/s12307-010-0060-5","journal-title":"Cancer Microenviron"},{"key":"11103_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1200\/JCO.2005.08.097","volume":"23","author":"ET Hawk","year":"2005","unstructured":"Hawk ET, Levin B (2005) Colorectal cancer prevention. J Clin Oncol 23:378\u2013391. https:\/\/doi.org\/10.1200\/JCO.2005.08.097","journal-title":"J Clin Oncol"},{"key":"11103_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3322\/canjclin.57.3.168","volume":"57","author":"BM Wolpin","year":"2007","unstructured":"Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ (2007) Adjuvant treatment of colorectal cancer. CA Cancer J Clin 57:168\u2013185. https:\/\/doi.org\/10.3322\/canjclin.57.3.168","journal-title":"CA Cancer J Clin"},{"key":"11103_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/cancers16111995","volume":"16","author":"TK Nikolouzakis","year":"2024","unstructured":"Nikolouzakis TK, Chrysos E, Docea AO et al (2024) Current and future trends of colorectal cancer treatment: exploring advances in immunotherapy. Cancers (Basel) 16:1995. https:\/\/doi.org\/10.3390\/cancers16111995","journal-title":"Cancers (Basel)"},{"key":"11103_CR6","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.1002\/cam4.5594","volume":"12","author":"S Ma","year":"2023","unstructured":"Ma S, Zhang J, Yan T et al (2023) Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med 12:11073\u201311096. https:\/\/doi.org\/10.1002\/cam4.5594","journal-title":"Cancer Med"},{"key":"11103_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"Y-H Xie","year":"2020","unstructured":"Xie Y-H, Chen Y-X, Fang J-Y (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5:22. https:\/\/doi.org\/10.1038\/s41392-020-0116-z","journal-title":"Signal Transduct Target Ther"},{"key":"11103_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/20406223231197311","author":"T Deng","year":"2023","unstructured":"Deng T, Duan J, Bai M et al (2023) Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study. Ther Adv Chronic Dis. https:\/\/doi.org\/10.1177\/20406223231197311","journal-title":"Ther Adv Chronic Dis"},{"key":"11103_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/ijms24021702","volume":"24","author":"T Ohishi","year":"2023","unstructured":"Ohishi T, Kaneko MK, Yoshida Y et al (2023) Current targeted therapy for metastatic colorectal cancer. Int J Mol Sci 24:1702. https:\/\/doi.org\/10.3390\/ijms24021702","journal-title":"Int J Mol Sci"},{"key":"11103_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"MdS Hossain","year":"2022","unstructured":"Hossain MdS, Karuniawati H, Jairoun AA et al (2022) Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors. Prev Treat Strateg Cancers (Basel) 14:1732. https:\/\/doi.org\/10.3390\/cancers14071732","journal-title":"Prev Treat Strateg Cancers (Basel)"},{"key":"11103_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X (2020) Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol 13:165. https:\/\/doi.org\/10.1186\/s13045-020-00990-3","journal-title":"J Hematol Oncol"},{"key":"11103_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/ijo.2022.5472","volume":"62","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chen M, Deng K (2022) Blocking the Wnt\/\u03b2-catenin signaling pathway to treat colorectal cancer: strategies to improve current therapies (Review). Int J Oncol 62:24. https:\/\/doi.org\/10.3892\/ijo.2022.5472","journal-title":"Int J Oncol"},{"key":"11103_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S et al (2022) Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer 21:144. https:\/\/doi.org\/10.1186\/s12943-022-01616-7","journal-title":"Mol Cancer"},{"key":"11103_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/CMAR.S411168","volume":"15","author":"K He","year":"2023","unstructured":"He K, Gan W-J (2023) Wnt\/\u03b2-catenin signaling pathway in the development and progression of colorectal cancer. Cancer Manag Res 15:435\u2013448. https:\/\/doi.org\/10.2147\/CMAR.S411168","journal-title":"Cancer Manag Res"},{"key":"11103_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.str.2007.12.021","volume":"16","author":"Y Xing","year":"2008","unstructured":"Xing Y, Takemaru K-I, Liu J et al (2008) Crystal structure of a full-length \u03b2-Catenin. Structure 16:478\u2013487. https:\/\/doi.org\/10.1016\/j.str.2007.12.021","journal-title":"Structure"},{"key":"11103_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.biopha.2018.11.082","volume":"110","author":"X Cheng","year":"2019","unstructured":"Cheng X, Xu X, Chen D et al (2019) Therapeutic potential of targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer. Biomed Pharmacother 110:473\u2013481. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.082","journal-title":"Biomed Pharmacother"},{"key":"11103_CR17","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/cells9092125","volume":"9","author":"J Bian","year":"2020","unstructured":"Bian J, Dannappel M, Wan C, Firestein R (2020) Transcriptional regulation of Wnt\/\u03b2-Catenin pathway in colorectal cancer. Cells 9:2125. https:\/\/doi.org\/10.3390\/cells9092125","journal-title":"Cells"},{"key":"11103_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.tibs.2018.06.003","volume":"43","author":"C Cui","year":"2018","unstructured":"Cui C, Zhou X, Zhang W et al (2018) Is \u03b2-Catenin a druggable target for cancer therapy? Trends Biochem Sci 43:623\u2013634. https:\/\/doi.org\/10.1016\/j.tibs.2018.06.003","journal-title":"Trends Biochem Sci"},{"key":"11103_CR19","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/cmdc.202000839","volume":"16","author":"D Kessler","year":"2021","unstructured":"Kessler D, Mayer M, Zahn SK et al (2021) Getting a grip on the undrugged: targeting \u03b2-catenin with fragment-based methods. ChemMedChem 16:1420\u20131424. https:\/\/doi.org\/10.1002\/cmdc.202000839","journal-title":"ChemMedChem"},{"key":"11103_CR20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4455","author":"L Ma","year":"2015","unstructured":"Ma L, Wang X, Jia T et al (2015) Tankyrase inhibitors attenuate WNT\/\u03b2-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.4455","journal-title":"Oncotarget"},{"key":"11103_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.7150\/jca.30976","volume":"11","author":"J Huang","year":"2020","unstructured":"Huang J, Qu Q, Guo Y et al (2020) Tankyrases\/\u03b2-catenin signaling pathway as an anti-proliferation and anti-metastatic target in hepatocarcinoma cell lines. J Cancer 11:432\u2013440. https:\/\/doi.org\/10.7150\/jca.30976","journal-title":"J Cancer"},{"key":"11103_CR22","doi-asserted-by":"publisher","first-page":"e48670","DOI":"10.1371\/journal.pone.0048670","volume":"7","author":"R Bao","year":"2012","unstructured":"Bao R, Christova T, Song S et al (2012) Inhibition of Tankyrases induces axin stabilization and blocks wnt signalling in breast cancer cells. PLoS ONE 7:e48670. https:\/\/doi.org\/10.1371\/journal.pone.0048670","journal-title":"PLoS ONE"},{"key":"11103_CR23","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1111\/cas.13805","volume":"109","author":"A Mizutani","year":"2018","unstructured":"Mizutani A, Yashiroda Y, Muramatsu Y et al (2018) <scp>RK<\/scp> -287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Cancer Sci 109:4003\u20134014. https:\/\/doi.org\/10.1111\/cas.13805","journal-title":"Cancer Sci"},{"key":"11103_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu J-J, Ding J (2021) Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect 11:5\u201313. https:\/\/doi.org\/10.1007\/s13659-020-00293-7","journal-title":"Nat Prod Bioprospect"},{"key":"11103_CR25","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.3390\/molecules25225365","volume":"25","author":"JW-F Law","year":"2020","unstructured":"Law JW-F, Law LN-S, Letchumanan V et al (2020) Anticancer drug discovery from microbial sources: the unique mangrove streptomycetes. Molecules 25:5365. https:\/\/doi.org\/10.3390\/molecules25225365","journal-title":"Molecules"},{"key":"11103_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2397808","volume":"2018","author":"K \u0141ukasiewicz","year":"2018","unstructured":"\u0141ukasiewicz K, Fol M (2018) Microorganisms in the treatment of cancer: advantages and limitations. J Immunol Res 2018:1\u20138. https:\/\/doi.org\/10.1155\/2018\/2397808","journal-title":"J Immunol Res"},{"key":"11103_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.semcancer.2021.05.006","volume":"86","author":"CD Mohan","year":"2022","unstructured":"Mohan CD, Rangappa S, Nayak SC et al (2022) Bacteria as a treasure house of secondary metabolites with anticancer potential. Semin Cancer Biol 86:998\u20131013. https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.006","journal-title":"Semin Cancer Biol"},{"key":"11103_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00284-022-02990-7","volume":"79","author":"S Pattnaik","year":"2022","unstructured":"Pattnaik S, Imchen M, Kumavath R et al (2022) Bioactive microbial metabolites in cancer therapeutics: mining, repurposing, and their molecular targets. Curr Microbiol 79:300. https:\/\/doi.org\/10.1007\/s00284-022-02990-7","journal-title":"Curr Microbiol"},{"key":"11103_CR29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"11103_CR30","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"11103_CR31","doi-asserted-by":"publisher","first-page":"D611","DOI":"10.1093\/nar\/gkac868","volume":"51","author":"DS Wishart","year":"2023","unstructured":"Wishart DS, Oler E, Peters H et al (2023) MiMeDB: the human microbial metabolome database. Nucleic Acids Res 51:D611\u2013D620. https:\/\/doi.org\/10.1093\/nar\/gkac868","journal-title":"Nucleic Acids Res"},{"key":"11103_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton GR, Paolini GV, Besnard J et al (2012) Quantifying the chemical beauty of drugs. Nat Chem 4:90\u201398. https:\/\/doi.org\/10.1038\/nchem.1243","journal-title":"Nat Chem"},{"key":"11103_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open Babel: An open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"11103_CR34","doi-asserted-by":"crossref","unstructured":"Sharma A, Yennamalli RM (2023) Docking strategies. In: Basic Biotechniques for Bioprocess and Bioentrepreneurship. Elsevier, pp 243\u2013258","DOI":"10.1016\/B978-0-12-816109-8.00016-7"},{"key":"11103_CR35","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian W, Chen C, Lei X et al (2018) CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res 46:W363\u2013W367. https:\/\/doi.org\/10.1093\/nar\/gky473","journal-title":"Nucleic Acids Res"},{"key":"11103_CR36","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"key":"11103_CR37","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816","journal-title":"J Comput Chem"},{"key":"11103_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"P Bjelkmar","year":"2010","unstructured":"Bjelkmar P, Larsson P, Cuendet MA et al (2010) Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J Chem Theory Comput 6:459\u2013466. https:\/\/doi.org\/10.1021\/ct900549r","journal-title":"J Chem Theory Comput"},{"key":"11103_CR39","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1063\/1.1808117","volume":"121","author":"DJ Price","year":"2004","unstructured":"Price DJ, Brooks CL (2004) A modified TIP3P water potential for simulation with Ewald summation. J Chem Phys 121:10096\u201310103. https:\/\/doi.org\/10.1063\/1.1808117","journal-title":"J Chem Phys"},{"key":"11103_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe K, Hatcher E, Acharya C et al (2010) CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem 31:671\u2013690. https:\/\/doi.org\/10.1002\/jcc.21367","journal-title":"J Comput Chem"},{"key":"11103_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/07391102.2020.1821785","volume":"40","author":"S Mathpal","year":"2022","unstructured":"Mathpal S, Joshi T, Sharma P et al (2022) A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor. J Biomol Struct Dyn 40:1084\u20131100. https:\/\/doi.org\/10.1080\/07391102.2020.1821785","journal-title":"J Biomol Struct Dyn"},{"key":"11103_CR42","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.3390\/molecules26185724","volume":"26","author":"SS Mousavi","year":"2021","unstructured":"Mousavi SS, Karami A, Haghighi TM et al (2021) In silico evaluation of iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2. Molecules 26:5724. https:\/\/doi.org\/10.3390\/molecules26185724","journal-title":"Molecules"},{"key":"11103_CR43","doi-asserted-by":"publisher","first-page":"120116","DOI":"10.1016\/j.molliq.2022.120116","volume":"365","author":"Q Ke","year":"2022","unstructured":"Ke Q, Gong X, Liao S et al (2022) Effects of thermostats\/barostats on physical properties of liquids by molecular dynamics simulations. J Mol Liq 365:120116. https:\/\/doi.org\/10.1016\/j.molliq.2022.120116","journal-title":"J Mol Liq"},{"key":"11103_CR44","doi-asserted-by":"publisher","first-page":"e0119264","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez L (2015) Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS ONE 10:e0119264. https:\/\/doi.org\/10.1371\/journal.pone.0119264","journal-title":"PLoS ONE"},{"key":"11103_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MYu Lobanov","year":"2008","unstructured":"Lobanov MYu, Bogatyreva NS, Galzitskaya OV (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628. https:\/\/doi.org\/10.1134\/S0026893308040195","journal-title":"Mol Biol"},{"key":"11103_CR46","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","volume":"15","author":"E Durham","year":"2009","unstructured":"Durham E, Dorr B, Woetzel N et al (2009) Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J Mol Model 15:1093\u20131108. https:\/\/doi.org\/10.1007\/s00894-009-0454-9","journal-title":"J Mol Model"},{"key":"11103_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.730288","author":"PP Kushwaha","year":"2021","unstructured":"Kushwaha PP, Singh AK, Bansal T et al (2021) Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2021.730288","journal-title":"Front Cell Infect Microbiol"},{"key":"11103_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1074342","author":"A DasNandy","year":"2022","unstructured":"DasNandy A, Patil VS, Hegde HV et al (2022) Elucidating type 2 diabetes mellitus risk factor by promoting lipid metabolism with gymnemagenin: an in vitro and in silico approach. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1074342","journal-title":"Front Pharmacol"},{"key":"11103_CR49","doi-asserted-by":"publisher","first-page":"108192","DOI":"10.1016\/j.jmgm.2022.108192","volume":"114","author":"B Kar","year":"2022","unstructured":"Kar B, Dehury B, Singh MK et al (2022) Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study. J Mol Graph Model 114:108192. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108192","journal-title":"J Mol Graph Model"},{"key":"11103_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1052849","author":"P Khanal","year":"2023","unstructured":"Khanal P, Patil VS, Bhandare VV et al (2023) Systems and in vitro pharmacology profiling of diosgenin against breast cancer. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1052849","journal-title":"Front Pharmacol"},{"key":"11103_CR51","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM et al (2012) MMPBSA.py\u202f: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","journal-title":"J Chem Theory Comput"},{"key":"11103_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4103\/1735-5362.359431","volume":"17","author":"Z Alimardan","year":"2022","unstructured":"Alimardan Z, Abbasi M, Khodarahmi G et al (2022) Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods. Res Pharm Sci 17:635\u2013656. https:\/\/doi.org\/10.4103\/1735-5362.359431","journal-title":"Res Pharm Sci"},{"key":"11103_CR53","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/molecules27041215","volume":"27","author":"AM Kulkarni","year":"2022","unstructured":"Kulkarni AM, Parate S, Lee G et al (2022) Computational simulations highlight the IL2R\u03b1 binding potential of polyphenol stilbenes from fenugreek. Molecules 27:1215. https:\/\/doi.org\/10.3390\/molecules27041215","journal-title":"Molecules"},{"key":"11103_CR54","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/bioinformatics\/btu761","volume":"31","author":"MK Matlock","year":"2015","unstructured":"Matlock MK, Hughes TB, Swamidass SJ (2015) XenoSite server: a web-available site of metabolism prediction tool. Bioinformatics 31:1136\u20131137. https:\/\/doi.org\/10.1093\/bioinformatics\/btu761","journal-title":"Bioinformatics"},{"key":"11103_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acscentsci.5b00131","volume":"1","author":"TB Hughes","year":"2015","unstructured":"Hughes TB, Miller GP, Swamidass SJ (2015) Modeling epoxidation of drug-like molecules with a deep machine learning network. ACS Cent Sci 1:168\u2013180. https:\/\/doi.org\/10.1021\/acscentsci.5b00131","journal-title":"ACS Cent Sci"},{"key":"11103_CR56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/acs.chemrestox.6b00385","volume":"30","author":"TB Hughes","year":"2017","unstructured":"Hughes TB, Swamidass SJ (2017) Deep learning to predict the formation of Quinone species in drug metabolism. Chem Res Toxicol 30:642\u2013656. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00385","journal-title":"Chem Res Toxicol"},{"key":"11103_CR57","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/acs.chemrestox.5b00017","volume":"28","author":"TB Hughes","year":"2015","unstructured":"Hughes TB, Miller GP, Swamidass SJ (2015) Site of reactivity models predict molecular reactivity of diverse chemicals with Glutathione. Chem Res Toxicol 28:797\u2013809. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00017","journal-title":"Chem Res Toxicol"},{"key":"11103_CR58","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1021\/acscentsci.6b00162","volume":"2","author":"TB Hughes","year":"2016","unstructured":"Hughes TB, Le DN, Miller GP, Swamidass SJ (2016) Modeling reactivity to biological macromolecules with a deep multitask network. ACS Cent Sci 2:529\u2013537. https:\/\/doi.org\/10.1021\/acscentsci.6b00162","journal-title":"ACS Cent Sci"},{"key":"11103_CR59","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1021\/acs.jcim.9b00836","volume":"60","author":"DN Le","year":"2020","unstructured":"Le DN, Matlock MK, Hughes TB, Swamidass SJ (2020) The metabolic rainbow: deep learning phase I metabolism in five colors. J Chem Inf Model 60:1146\u20131164. https:\/\/doi.org\/10.1021\/acs.jcim.9b00836","journal-title":"J Chem Inf Model"},{"key":"11103_CR60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1021\/acs.chemrestox.7b00191","volume":"31","author":"DN Le","year":"2018","unstructured":"Le DN, Hughes TB, Miller GP, Swamidass SJ (2018) Computationally assessing the bioactivation of drugs by N-Dealkylation. Chem Res Toxicol 31:68\u201380. https:\/\/doi.org\/10.1021\/acs.chemrestox.7b00191","journal-title":"Chem Res Toxicol"},{"key":"11103_CR61","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1093\/bioinformatics\/btw350","volume":"32","author":"DN Le","year":"2016","unstructured":"Le DN, Hughes TB, Krishnamurthy V, Swamidass SJ (2016) A simple model predicts UGT-mediated metabolism. Bioinformatics 32:3183\u20133189. https:\/\/doi.org\/10.1093\/bioinformatics\/btw350","journal-title":"Bioinformatics"},{"key":"11103_CR62","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.toxrep.2022.05.012","volume":"9","author":"SK Gupta","year":"2022","unstructured":"Gupta SK, Jadhav S, Gohil D et al (2022) Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice. Toxicol Rep 9:1204\u20131212. https:\/\/doi.org\/10.1016\/j.toxrep.2022.05.012","journal-title":"Toxicol Rep"},{"key":"11103_CR63","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10886-024-01482-1","volume":"50","author":"Y Chen","year":"2024","unstructured":"Chen Y, Lafleur C, Smith RJ et al (2024) Trichoplusia ni transcriptomic responses to the phytosaponin aglycone hederagenin: sex-related differences. J Chem Ecol 50:168\u2013184. https:\/\/doi.org\/10.1007\/s10886-024-01482-1","journal-title":"J Chem Ecol"},{"key":"11103_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s40203-021-00113-x","volume":"9","author":"R Pawara","year":"2021","unstructured":"Pawara R, Ahmad I, Surana S, Patel H (2021) Computational identification of 2,4-disubstituted amino-pyrimidines as L858R\/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation. In Silico Pharmacol 9:54. https:\/\/doi.org\/10.1007\/s40203-021-00113-x","journal-title":"In Silico Pharmacol"},{"key":"11103_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1127201","author":"S Rehman","year":"2023","unstructured":"Rehman S, Bhatti A, John P (2023) Computational analysis to investigate the anti-rheumatic potential of plant-based small molecule inhibitor targeting tumor necrosis factor \u03b1. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1127201","journal-title":"Front Pharmacol"},{"key":"11103_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/chin.200910274","author":"D Filimonov","year":"2009","unstructured":"Filimonov D, Poroikov V (2009) ChemInform abstract: probabilistic approaches in activity prediction. ChemInform. https:\/\/doi.org\/10.1002\/chin.200910274","journal-title":"ChemInform"},{"key":"11103_CR67","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1021\/ci000383k","volume":"40","author":"VV Poroikov","year":"2000","unstructured":"Poroikov VV, Filimonov DA, Borodina YuV et al (2000) Robustness of biological activity spectra predicting by computer program pass for noncongeneric sets of chemical compounds. J Chem Inf Comput Sci 40:1349\u20131355. https:\/\/doi.org\/10.1021\/ci000383k","journal-title":"J Chem Inf Comput Sci"},{"key":"11103_CR68","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"V DE Pires","year":"2015","unstructured":"DE Pires V, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"11103_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021689","author":"AA Lagunin","year":"2023","unstructured":"Lagunin AA, Rudik AV, Pogodin PV et al (2023) CLC-Pred 2.0: a freely available web application for in silico prediction of human cell line cytotoxicity and molecular mechanisms of action for druglike compounds. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021689","journal-title":"Int J Mol Sci"},{"key":"11103_CR70","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/prot.22922","volume":"79","author":"A Bornot","year":"2011","unstructured":"Bornot A, Etchebest C, de Brevern AG (2011) Predicting protein flexibility through the prediction of local structures. Proteins: Struct Funct Bioinform 79:839\u2013852. https:\/\/doi.org\/10.1002\/prot.22922","journal-title":"Proteins: Struct Funct Bioinform"},{"key":"11103_CR71","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1073\/pnas.85.14.5067","volume":"85","author":"H Vogel","year":"1988","unstructured":"Vogel H, Nilsson L, Rigler R et al (1988) Structural fluctuations of a helical polypeptide traversing a lipid bilayer. Proc Natl Acad Sci 85:5067\u20135071. https:\/\/doi.org\/10.1073\/pnas.85.14.5067","journal-title":"Proc Natl Acad Sci"},{"key":"11103_CR72","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1073\/pnas.0808581106","volume":"106","author":"B Fierz","year":"2009","unstructured":"Fierz B, Reiner A, Kiefhaber T (2009) Local conformational dynamics in \u03b1-helices measured by fast triplet transfer. Proc Natl Acad Sci 106:1057\u20131062. https:\/\/doi.org\/10.1073\/pnas.0808581106","journal-title":"Proc Natl Acad Sci"},{"key":"11103_CR73","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1021\/jm2010332","volume":"55","author":"DJ Huggins","year":"2012","unstructured":"Huggins DJ, Sherman W, Tidor B (2012) Rational approaches to improving selectivity in drug design. J Med Chem 55:1424\u20131444. https:\/\/doi.org\/10.1021\/jm2010332","journal-title":"J Med Chem"},{"key":"11103_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/prot.22579","volume":"78","author":"S Henrich","year":"2010","unstructured":"Henrich S, Feierberg I, Wang T et al (2010) Comparative binding energy analysis for binding affinity and target selectivity prediction. Proteins: structure. Funct Bioinform 78:135\u2013153. https:\/\/doi.org\/10.1002\/prot.22579","journal-title":"Funct Bioinform"},{"key":"11103_CR75","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1080\/07391102.2020.1850355","volume":"40","author":"MdO Rafi","year":"2022","unstructured":"Rafi MdO, Bhattacharje G, Al-Khafaji K et al (2022) Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19. J Biomol Struct Dyn 40:3711\u20133730. https:\/\/doi.org\/10.1080\/07391102.2020.1850355","journal-title":"J Biomol Struct Dyn"},{"key":"11103_CR76","doi-asserted-by":"publisher","first-page":"11291","DOI":"10.1038\/s41598-024-61387-7","volume":"14","author":"HF Hashmi","year":"2024","unstructured":"Hashmi HF, Xuan X, Chen K et al (2024) Molecular modeling and simulation approaches to characterize potential molecular targets for burdock inulin to instigate protection against autoimmune diseases. Sci Rep 14:11291. https:\/\/doi.org\/10.1038\/s41598-024-61387-7","journal-title":"Sci Rep"},{"key":"11103_CR77","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1038\/s41598-023-33024-2","volume":"13","author":"OA Durojaye","year":"2023","unstructured":"Durojaye OA, Okoro NO, Odiba AS, Nwanguma BC (2023) MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference. Sci Rep 13:6972. https:\/\/doi.org\/10.1038\/s41598-023-33024-2","journal-title":"Sci Rep"},{"key":"11103_CR78","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/biom11060798","volume":"11","author":"S Basith","year":"2021","unstructured":"Basith S, Manavalan B, Shin TH, Lee G (2021) Mapping the intramolecular communications among different glutamate dehydrogenase states using molecular dynamics. Biomolecules 11:798. https:\/\/doi.org\/10.3390\/biom11060798","journal-title":"Biomolecules"},{"key":"11103_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1403127","author":"R Munir","year":"2024","unstructured":"Munir R, Zaib S, Zia-ur-Rehman M et al (2024) Exploration of morpholine-thiophene hybrid thiosemicarbazones for the treatment of ureolytic bacterial infections via targeting urease enzyme: Synthesis, biochemical screening and computational analysis. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2024.1403127","journal-title":"Front Chem"},{"key":"11103_CR80","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/molecules27030917","volume":"27","author":"SS Hassan","year":"2022","unstructured":"Hassan SS et al (2022) A comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of vieloplain f from xylopia vielana targeting B-Raf kinase. Molecules 27:917. https:\/\/doi.org\/10.3390\/molecules27030917","journal-title":"Molecules"},{"key":"11103_CR81","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1021\/ml300105s","volume":"3","author":"T El-Elimat","year":"2012","unstructured":"El-Elimat T, Zhang X, Jarjoura D et al (2012) Chemical diversity of metabolites from fungi, cyanobacteria, and plants relative to FDA-approved anticancer agents. ACS Med Chem Lett 3:645\u2013649. https:\/\/doi.org\/10.1021\/ml300105s","journal-title":"ACS Med Chem Lett"},{"key":"11103_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ja.2005.1","volume":"58","author":"J B\u00e9rdy","year":"2005","unstructured":"B\u00e9rdy J (2005) Bioactive microbial metabolites. J Antibiot (Tokyo) 58:1\u201326. https:\/\/doi.org\/10.1038\/ja.2005.1","journal-title":"J Antibiot (Tokyo)"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11103-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:29:09Z","timestamp":1763728149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11103-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11103"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11103-4","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}